Any feedback?
Literature summary extracted from
- Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes (1997), Br. J. Clin. Pharmacol., 44, 505-511 .
Activating Compound
| EC Number | Activating Compound | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.14.14.55 | additional information | not activated by 0.025 mM 2-naphthoflavone | Homo sapiens |
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.14.14.55 | cimetidine | - |
Homo sapiens |  |
| 1.14.14.55 | diltiazem | - |
Homo sapiens | |
| 1.14.14.55 | doxycycline | - |
Homo sapiens | |
| 1.14.14.55 | erythromycin | - |
Homo sapiens | |
| 1.14.14.55 | hydralazine | - |
Homo sapiens | |
| 1.14.14.55 | ketoconazole | - |
Homo sapiens | |
| 1.14.14.55 | additional information | not inhibited by lignocaine, pyrimethamine, dapsone, chloroquine, diazepam, norfloxacin, proguanil, cycloguanil, and 4-chlorophenylbiguanide | Homo sapiens | |
| 1.14.14.55 | nifepidine | - |
Homo sapiens | |
| 1.14.14.55 | oleandomycin | - |
Homo sapiens | |
| 1.14.14.55 | Omeprazole | - |
Homo sapiens | |
| 1.14.14.55 | primaquine | - |
Homo sapiens | |
| 1.14.14.55 | tetracycline | - |
Homo sapiens | |
| 1.14.14.55 | troleandomycin | - |
Homo sapiens | |
| 1.14.14.55 | verapamil | - |
Homo sapiens | |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 1.14.14.55 | microsome | - |
Homo sapiens | - |
- |
Natural Substrates/ Products (Substrates)
| EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.14.14.55 | quinine + [reduced NADPH-hemoprotein reductase] + O2 | Homo sapiens | - |
3-hydroxyquinine + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.14.14.55 | Homo sapiens | - |
- |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 1.14.14.55 | liver | - |
Homo sapiens | - |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.14.14.55 | quinine + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | 3-hydroxyquinine + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? | |
| 1.14.14.55 | tacrolimus + [reduced NADPH-hemoprotein reductase] + O2 | - |
Homo sapiens | ? | - |
? | |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 1.14.14.55 | CYP3A4 | - |
Homo sapiens |
IC50 Value
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 1.14.14.55 | 0.000026 | - |
at pH 7.4 and 37°C | Homo sapiens | ketoconazole | |
| 1.14.14.55 | 0.0083 | - |
at pH 7.4 and 37°C | Homo sapiens | troleandomycin | |
| 1.14.14.55 | 0.017 | - |
at pH 7.4 and 37°C | Homo sapiens | doxycycline | |
| 1.14.14.55 | 0.018 | - |
at pH 7.4 and 37°C | Homo sapiens | Omeprazole | |
| 1.14.14.55 | 0.02 | - |
at pH 7.4 and 37°C | Homo sapiens | primaquine | |
| 1.14.14.55 | 0.029 | - |
at pH 7.4 and 37°C | Homo sapiens | tetracycline | |
| 1.14.14.55 | 0.038 | - |
at pH 7.4 and 37°C | Homo sapiens | nifepidine | |
| 1.14.14.55 | 0.061 | - |
at pH 7.4 and 37°C | Homo sapiens | erythromycin | |
| 1.14.14.55 | 0.064 | - |
at pH 7.4 and 37°C | Homo sapiens | verapamil | |
| 1.14.14.55 | 0.097 | - |
at pH 7.4 and 37°C | Homo sapiens | cimetidine | |
| 1.14.14.55 | 0.127 | - |
at pH 7.4 and 37°C | Homo sapiens | diltiazem | |
| 1.14.14.55 | 0.143 | - |
at pH 7.4 and 37°C | Homo sapiens | oleandomycin | |
| 1.14.14.55 | 0.197 | - |
at pH 7.4 and 37°C | Homo sapiens | hydralazine | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
